|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Anthranilic acidamides:a novel class of antiangiogenic VEGF receptor kinase inhibitors 显示文摘 | MANLEY PW FURET P BOLD G | 2002 | J Med Chem2002，45，26： | 1 |
| 2 | Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia 显示文摘 | Weisberg E Manley PW Cowan-Jacob SW | 2007 | Nat Rev Cancer2007，7，5： | 1 |
| 3 | Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl显示文摘 | WEISBERG E MANLEY PW BREITENSTEIN W | 2005 | Cancer Cell2005，7，2： | 1 |
| 4 | The kinetic deuterium i- sotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588 显示文摘 | Manley PW Blasco F Mestan J | 2013 | Bioorgan Med Chem2013，21，11： | 1 |
| 5 | AMN107 (nilotinib) : a novel and selective inhibitor of BCR-ABL显示文摘 | WEISBERG E MANLEY PW MESTAN J | 2006 | Br J Cancer2006，94，12： | 1 |
| 6 | KCO912:a potent and selective opener of ATP - dependent potassium( K(ATP) )channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects 显示文摘 | Buchheit KH Manley PW Quast U | 2002 | Naunyn Schmiedebergs Arch Pharmacol2002，365，3： | 1 |
| 7 | Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl显示文摘 | WEISBERG E MANLEY PW BREITENSTEIN W et ol | 2005 | Cancer Cell2005，7，2： | 1 |
| 8 | Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors 显示文摘 | Manley PW Furet P Bold G | 2002 | Med Chem2002，45，26： | 1 |
| 9 | The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite,CGP74588显示文摘 | Manley PW Blasco F Mestan J | 2013 | Bioorg Med Chem2013，21，11： | 1 |
| 10 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 11 | Su-6668,SUGEN显示文摘 | Fabbro D Manley PW | 2001 | Curr Opin Investig Drugs2001，2，8： | 1 |
| 12 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer cell2005，7，2： | 1 |
| 13 | Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia显示文摘 | Weisberg E Manley PW Cowan-Jacob SW | 2007 | Nat Rev Cancer2007，7，5： | 1 |
| 14 | Characterization of AMN107,a Selective Inhibitor of Native and Mutant显示文摘 | Manley PW Breitenstein W | 2005 | Bcr-AbL Cancer Cell2005，7，12： | 1 |
| 15 | Characterization of AMN107,a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | | 0，，02： | 1 |
| 16 | Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl 显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Cancer Cell2005，7，2： | 1 |
| 17 | Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia显示文摘 | Weisberg E Manley PW Cowan-Jacob SW | 2007 | Nat Rev Cancer2007，7，5： | 1 |
| 18 | Charac terization of AMN107, a selective inhibitor of native and mutant Bcr-Abl显示文摘 | Weisberg E Manley PW Breitenstein W | 2005 | Canc Cell2005，7，4： | 1 |
| 19 | Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid lenkaemia显示文摘 | Weisberg E Manley PW Cowan-Jacob SW | 2007 | Nat Rev Cancer2007，7，5： | 1 |
| 20 | Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukemia 显示文摘 | Weisberg E Manley PW Cowan-Jacob SW | 2007 | Nat Rev Cancer2007，7，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员